In addition, glutamine synthetase (GS), which is downstream of the Wnt/β-catenin pathway, promotes mTORC1 activation in normal liver and HCC, highlighting the important oncogenic role of the Wnt/β-catenin pathway and the mTORC1 signaling cascade in HCC [75]. Here, GLUL is linked to hepatocellular carcinoma.